Loading...
MTI Ltd.
9438.T•JPX
Healthcare
Medical - Healthcare Information Services
¥915.00
¥-13.00(-1.40%)
MTI Ltd. (9438.T) Financial Performance & Income Statement Overview
Review MTI Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.25%
↑ 3.25%
Operating Income Growth
702.28%
↑ 702.28%
Net Income Growth
213.84%
↑ 213.84%
Operating Cash Flow Growth
-13.29%
↓ 13.29%
Operating Margin
10.26%
↑ 10.26%
Gross Margin
74.36%
↑ 74.36%
Net Profit Margin
8.82%
↑ 8.82%
ROE
16.11%
↑ 16.11%
ROIC
12.47%
↑ 12.47%
MTI Ltd. (9438.T) Income Statement & Financial Overview
Review MTI Ltd.'s (9438.T) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $7.27B | $7.13B | $7.02B | $6.89B |
| Cost of Revenue | $1.86B | $1.82B | $1.83B | $1.82B |
| Gross Profit | $5.41B | $5.31B | $5.19B | $5.07B |
| Gross Profit Ratio | $0.74 | $0.74 | $0.74 | $0.74 |
| R&D Expenses | $0.00 | $158.00M | $0.00 | $41.00M |
| SG&A Expenses | $4.36B | $4.31B | $4.49B | $4.41B |
| Operating Expenses | $4.69B | $4.67B | $4.49B | $4.45B |
| Total Costs & Expenses | $6.55B | $6.49B | $6.32B | $6.28B |
| Interest Income | $44000.00 | $0.00 | $19000.00 | $33000.00 |
| Interest Expense | $3.93M | $0.00 | $3.22M | $2.34M |
| Depreciation & Amortization | $427.31M | $427.00M | $428.95M | $427.14M |
| EBITDA | $1.14B | $1.07B | $1.38B | $1.89B |
| EBITDA Ratio | $0.16 | $0.15 | $0.20 | $0.27 |
| Operating Income | $718.33M | $641.72M | $699.85M | $616.98M |
| Operating Income Ratio | $0.10 | $0.09 | $0.10 | $0.09 |
| Other Income/Expenses (Net) | $143.48M | -$371.06M | $247.08M | $841.33M |
| Income Before Tax | $861.80M | $270.66M | $946.92M | $1.46B |
| Income Before Tax Ratio | $0.12 | $0.04 | $0.13 | $0.21 |
| Income Tax Expense | $249.68M | $135.81M | $252.92M | $504.17M |
| Net Income | $589.06M | $119.26M | $684.95M | $928.31M |
| Net Income Ratio | $0.08 | $0.02 | $0.10 | $0.13 |
| EPS | $10.67 | $2.17 | $12.47 | $16.92 |
| Diluted EPS | $10.67 | $2.17 | $12.45 | $16.91 |
| Weighted Avg Shares Outstanding | $55.21M | $55.00M | $54.92M | $54.86M |
| Weighted Avg Shares Outstanding (Diluted) | $55.21M | $55.08M | $55.000M | $54.89M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan